BEYOND AIR INC (XAIR)
US08862L1035 - Common Stock
Taking everything into account, XAIR scores 2 out of 10 in our fundamental rating. XAIR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XAIR have multiple concerns. XAIR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year XAIR has reported negative net income.
In the past year XAIR has reported a negative cash flow from operations.
In the past 5 years XAIR always reported negative net income.
XAIR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
XAIR's Return On Assets of -125.48% is on the low side compared to the rest of the industry. XAIR is outperformed by 87.17% of its industry peers.
XAIR has a Return On Equity of -361.76%. This is amonst the worse of the industry: XAIR underperforms 85.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -125.48% | ||
| ROE | -361.76% | ||
| ROIC | N/A |
ROA(3y)-76.83%
ROA(5y)-72.3%
ROE(3y)-149.03%
ROE(5y)-127.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XAIR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XAIR has more shares outstanding
XAIR has more shares outstanding than it did 5 years ago.
XAIR has a worse debt/assets ratio than last year.
2.2 Solvency
XAIR has an Altman-Z score of -10.62. This is a bad value and indicates that XAIR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XAIR (-10.62) is worse than 80.21% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that XAIR is somewhat dependend on debt financing.
XAIR's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. XAIR is outperformed by 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -10.62 |
ROIC/WACCN/A
WACC10.9%
2.3 Liquidity
XAIR has a Current Ratio of 2.63. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
XAIR has a Current ratio (2.63) which is comparable to the rest of the industry.
A Quick Ratio of 2.42 indicates that XAIR has no problem at all paying its short term obligations.
XAIR has a Quick ratio (2.42) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.63 | ||
| Quick Ratio | 2.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.55% over the past year.
Measured over the past years, XAIR shows a very negative growth in Revenue. The Revenue has been decreasing by -31.56% on average per year.
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.1%
Revenue 1Y (TTM)N/A
Revenue growth 3Y10.03%
Revenue growth 5Y-31.56%
Sales Q2Q%234.73%
3.2 Future
XAIR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.84% yearly.
The Revenue is expected to grow by 256.46% on average over the next years. This is a very strong growth
EPS Next Y47.09%
EPS Next 2Y31.09%
EPS Next 3Y23.84%
EPS Next 5YN/A
Revenue Next Year485%
Revenue Next 2Y375.69%
Revenue Next 3Y256.46%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for XAIR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XAIR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
XAIR's earnings are expected to grow with 23.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.09%
EPS Next 3Y23.84%
5. Dividend
5.1 Amount
No dividends for XAIR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BEYOND AIR INC
NASDAQ:XAIR (11/22/2024, 8:13:56 PM)
After market: 0.55 +0.01 (+1.85%)0.54
+0.02 (+3.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.98M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -125.48% | ||
| ROE | -361.76% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.63 | ||
| Quick Ratio | 2.42 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y47.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3Y10.03%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y